Analyst Ratings for Lexicon Pharmaceuticals (LXRX) [Buys]
LXRX Rating Summary
LXRX Price Target Summary
- Highest: $4.00 (Citi)
- Lowest: $4.00 (Citi)
- Average: $4.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$4.00 (+118.6%)
* Over Last 12-Mos
Rating Score: 2.5 / 10
Percentile Rank: 20%
Rating Score: 2.5 / 10
Percentile Rank: 20%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/12/2022 | Piper Sandler | Yasmeen Rahimi | New Coverage | Overweight (N/A) |
10.00 (N/A) |
2.78 (1.83) |
-34.17% | Details |
| 12/8/2020 | Citi » Updated 12/12/2023 |
Yigal Nochomovitz | Upgrade | Buy (Neutral) |
4.00 (5.00) |
1.58 (1.83) |
15.82% | Details |
 |
||||||||
